DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Erratum for Karanam et al., Drug Metab Dispos 32 (9) 1015-1022.
Erratum for Liu et al., Drug Metab Dispos 32 (9) 1023-1031.
Erratum for Donovan et al., Drug Metab Dispos 32 (9) 906-908.
Erratum for Roerig et al., Drug Metab Dispos 32 (9) 953-958.
Erratum for Jones and Houston, Drug Metab Dispos 32 (9) 973-982.
0090-9556/04/3211-1331-$20.00
DMD 32:1331-, 2004

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
ERRATUM

CORRECTION to September Issue of Drug Metabolism and Disposition

In the September issue of Drug Metabolism and Disposition, the following articles were published in the print version with an incorrect URL in the footnote "Article, publication date, and citation information can be found at...":

Donovan JL, Chavin KD, Devane CL, Taylor RM, Wang J-S, Ruan Y, and Markowitz JS (2004) Green tea (Camellia sinensis) extract does not alter cytochrome P450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos 32:906–908.

Roerig DL, Audi SH, and Ahlf SB (2004) Kinetic characterization of P-glycoprotein-mediated efflux of rhodamine 6G in the intact rabbit lung. Drug Metab Dispos 32:953–958.

Jones HM and Houston JB (2004) Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations. Drug Metab Dispos 32:973–982.

Karanam BV, Hop CECA, Liu DQ, Wallace M, Dean D, Satoh H, Komuro M, Awano K, and Vincent H (2004) In vitro metabolism of MK-0767 [(±)-5-[(2,4-dioxothiazolidin-5-YL)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor / agonist. I. Role of cytochrome P450, methyltransferases, flavin monooxygenases, and esterases. Drug Metab Dispos 32:1015–1022.

Liu DQ, Karanam BV, Doss GA, Sidler RR, Vincent SH, and Hop CECA (2004) In vitro metabolism of MK-0767 [(±)-5-[(2,4-dioxothiazolidin-5-YL)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor {alpha}/{gamma} agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometry. Drug Metab Dispos 32:1023–1031.

The correct URL is http://dmd.aspetjournals.org. The online version has been corrected in departure from the print version.

We regret any confusion or inconvenience caused by this typographical error.





This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition